$2.21
arrow_drop_down14.20%Key Stats | |
---|---|
Open | $2.59 |
Prev. Close | $2.57 |
EPS | -1.44 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $181.05M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.15 | 2.60 |
52 Week Range | 1.66 | 7.01 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.44 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Tenaya Therapeutics Announces Research Leadership Updates
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine